【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2012 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2012 9
2.2.1 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion 9
2.2.2 Teva Pharma Completes Public Offering of Notes for $2 Billion 9
2.2.3 HCA Completes Public Offering of Notes Due 2021 for $1 Billion 10
2.2.4 Mylan Prices Private Placement of Notes Due 2023 for $750 Million 10
2.2.5 Mitsubishi Chemical to Acquire Qualicaps from Carlyle Group for $660 Million 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2012 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2012 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2012 13
3.1.1 Top M&A Deals in December 2012 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2012-December 2012 14
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2012 15
3.2.1 Top Equity Offering Deals in December 2012 16
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2012 – December 2012 16
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2012 17
3.3.1 Top PE/VC Deals in December 2012 18
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2012 19
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2012 20
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2012 – December 2012 21
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2012 – December 2012 22
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012 23
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012 23
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2012 – December 2012 24
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2012 25
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2012 25
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2012 – December 2012 26
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2012 – December 2012 27
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2012 – December 2012 28
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2012 – December 2012 29
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012 30
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012 30
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2012 31
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2012 32
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2012 32
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2012 33
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2012 – December 2012 34
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2012 – December 2012 35
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2012 – December 2012 36
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2012 – December 2012 37
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 39
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2012 39
6.1.1 Oncology – Deals of the Month 40
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2012 41
6.2.1 Central Nervous System – Deals of the Month 42
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2012 43
6.3.1 Infectious Diseases – Deals of the Month 44
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2012 45
6.4.1 Metabolic Disorders – Deal of the Month 46
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2012 47
6.5.1 Immunology – Deal of the Month 48
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2012 49
6.6.1 Cardiovascular – Deal of the Month 50
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, December 2012 51
6.7.1 Gastrointestinal – Deals of the Month 52
7 Deal Summary by Geography 53
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2012 53
7.1.1 North America – Deals of the Month 54
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2012 55
7.2.1 Europe – Deals of the Month 56
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2012 57
7.3.1 Asia-Pacific – Deals of the Month 58
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2012 59
7.4.1 Rest of the World – Deals of the Month 60
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 61
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2012 – December 2012 61
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2012 – December 2012 62
9 Further Information 63
9.1 Methodology 63
9.2 About GlobalData 64
9.3 Contact Us 64
9.4 Disclosure information 64
9.5 Disclaimer 64
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：December 2012（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals
■ 発行日：2013年1月14日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160054
■ 調査対象地域：グローバル
- Connacher Oil and Gas Limited：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Connacher Oil and Gas Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Connacher Oil and Gas Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- Royal Dutch Shell plc：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- アルコール性肝炎(Alcoholic Hepatitis)：治療薬開発パイプライン動向（2015年上半期版）Alcoholic Hepatitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H1 2015’, provides an overview of the Alcoholic Hepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- 世界のデータ分析アウトソーシング市場（2014-2018）About Data Analytics Outsourcing Data analytics is the process that helps an organization to gain insights from large sets of data. It helps in comprehending the information hidden within the data and improve the business decision-making process. It provides insights about customer behaviour and market insights. Therefore, data analytics outsourcing is the process in which organizations employ ser …
- 妊娠検査キット（カード/カセット型）の世界市場About Pregnancy Detection Card Pregnancy detection cards are diagnostic products that check for chemical markers related to pregnancy. The card or cassette format is one of the three categories under rapid pregnancy tests. The remaining two are the strip format and the midstream format. Pregnancy detection cards use the chromatographic immunoassay technique for the detection of hCG in urine to det …
- ナッツ成分の世界市場：アーモンド、ヘーゼルナッツ、クルミ、カシューナッツThe nut ingredients market, in terms of volume, is projected to reach 1,946.8 MT in 2014 at a CAGR of 5.7% from 2014 to 2019. Nut ingredients are widely used in the food industry to enhance the taste and value to the foods such as confectioneries, dairy, bakery, snacks & bars, desserts, cereals, beverages, and others. Rising consumer demand for health-based foods and innovative food products are d …
- 流量計の世界市場予測（～2022年）：差圧式流量計、容積式流量計、電磁式流量計、超音波式流量計、コリオリ式流量計、タービン流量計、渦流量計The flow meters market is projected to grow from USD 6.81 Billion in 2017 to USD 9.30 Billion by 2022, at a CAGR of 6.42% from 2017 to 2022. The growth of this market can be attributed to the increasing demand from oil & gas and water & waste water industries. The flow meters market has been segmented on the basis of type, end-use industry, and region. On the basis of type, the flow meters market …
- ビデオゲームの世界市場The global market for video games represents a total of nearly 62bn€ in 2014 and we estimate a strong CAGR of 8.5% for the period 2014-2018. This study follows the development of key indicators for the sector over five years and makes an appraisal of the key segments: • Home consoles • Handheld consoles • Offline computer games • Online computer games • Smartphone Game Market • Tablet Game Market …
- 産業用ワイヤレスオートメーションの世界市場2019-2023About this market Wireless technologies have evolved over the years to simplify business operations across the end-user industries. Advances in wireless solutions have empowered end-users to deploy M2M services for managing several facets of business. The major factor driving the M2M communications is the pervasive accessibility of low cost, ubiquitous connectivity. M2M, in general, is a next-gene …
- 脳神経血管内治療用コイルの世界市場2015-2019About Neuroendovascular Coil A neuroendovascular coil is used to treat an unruptured and ruptured brain aneurysm (a weakened area in the artery wall). The treatment is either known as an endovascular coiling or endovascular embolization. During this procedure, the endovascular coil blocks the blood flow in an aneurysm. The endovascular coiling treatment is usually performed under general anaesthes …
- 世界のUAV(無人航空機)リモートセンシング市場動向（2014-2018）About Airborne UAV Remote Sensing UAV remote sensing is used to acquire information about material objects or a specified area from the air without any physical contact with the object or area under investigation. Remote sensing data can also be collected from devices (satellites) in space. UAV remote sensing is primarily used in the aerospace industry where self-piloted aircraft carrying sensors, …
- 光増幅器の世界市場2019-2023About this market The rising demand for data storage and computation, there is an increasing adoption of cloud computing networks. These cloud systems can be implemented with the help of hyper-converged infrastructure (HCI) framework. This enables organizations to adopt virtualization, software-defined storage, and virtualized networking, to reduce the complexity of their data centers. As a result …
- 婦人科系癌の世界市場2019-2023About this market Gynecological cancers are one amongst the most frequently diagnosed cancers in women after breast cancer. The incidence of gynecological cancers such as cervical, uterine, and ovarian cancer is dramatically increasing throughout the world. The increasing incidence can be attributed to risk factors such as obesity, viral infections, smoking, and immune system deficiency. Regional …
- 自動車用インナーフェンダーの世界市場About Automotive Inner FendersEach vehicle is equipped with inner fenders. It is mounted above all the wheels to protect the engine components from road debris. Technavio’s analysts forecast the global Automotive Inner Fenders market to grow at a CAGR of 4.62% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global automot …
- 軍事リースの世界市場2016-2026Now: Why is the Military Leasing important right now? As part of the broader Military Leasing market space, there are massive revenue streams within the unmanned systems submarket to tap into. This report shows you where these business opportunities are. Due to a myriad of real and perceived threats, never before have government and private enterprise been so concerned with protecting their busine …
